Quoin Pharmaceuticals, Ltd. (QNRX) Reports Q2 Loss of $3.24/sh

Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) reported Q2 EPS of ($3.24), versus ($18.05) reported last year.

For earnings history and earnings-related data on Quoin Pharmaceuticals, Ltd. (QNRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Goldman reinstates Estee Lauder rating, sees turnaround driving growth and margins
• Morgan Stanley sees little room left in steel rally, cuts Cleveland-Cliffs rating